Breaking Down Tirzepatide Costs: Pricing and Savings

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub — plain-language guidance on GLP-1 therapies, weight-management protocols, and the genetic variables behind every metabolic decision.

The plural in "tirzepatide costs" is fitting, because there is no one cost — there are several, stacked and interacting. Tirzepatide is among the most-searched GLP-1 medications in the U.S. as of April 2026, and the questions that follow are almost always about money. This breakdown separates the components one at a time, reported as published rather than promised, so you can see exactly where each dollar comes from before deciding.

Component one: the list price

Tirzepatide's list price is approximately $1,059 to $1,069 per month at U.S. list as of April 2026, reflecting Eli Lilly published pricing for Zepbound and Mounjaro. Out-of-pocket cost then varies with insurance coverage, the FDA-approved indication on the prescription, manufacturer savings programs, and the pharmacy filling it. List price is rarely what most insured patients actually pay.

Component two: coverage and the indication

Coverage depends on whether the prescription is for an FDA-approved indication and on the specific plan formulary. Many commercial plans cover tirzepatide for type 2 diabetes; coverage for chronic weight management is more variable and often subject to prior authorization or BMI-based criteria. Confirm your plan's rules directly as of April 2026 rather than relying on general guidance.

Component three: savings and discounts

Tirzepatide is marketed under Mounjaro for type 2 diabetes and Zepbound for chronic weight management, and it is also available through licensed compounding pharmacy pathways.

Manufacturer card

The manufacturer publishes a savings-card program that can substantially reduce monthly out-of-pocket cost for eligible commercially-insured patients.

Independent coupons

Platforms like GoodRx and SingleCare publish coupon prices that vary by pharmacy. Eligibility and savings amounts change over time, so verify at the time of fill.

Component four: compounded alternatives

Between 2022 and 2024, the FDA listed tirzepatide on its drug shortage list, opening a pathway for licensed 503A compounding pharmacies to compound tirzepatide formulations. The FDA resolved the tirzepatide shortage in 2024, narrowing but not eliminating that pathway. Legitimate compounded protocols, prescribed by a licensed clinician through a state-licensed compounding pharmacy, remain a real option, though pricing and access vary widely.

Component five: the PlexusDx protocol lane

PlexusDx offers clinician-supervised compounded GLP-1 protocols inside its Weight Management Protocols, spanning semaglutide and tirzepatide in injectable and oral forms alongside microdose and combination options. Current pricing appears on each product page as of April 2026. This is a distinct lane from a branded pharmacy purchase, with its own clinical oversight and cost structure.

How the components interact

These pieces do not sit in isolation; they modify one another, which is why the final number is hard to predict. Coverage can make a coupon irrelevant, since an insured copay may already beat any discount card. A savings-card cap can quietly undo an early-year bargain months later. The indication on the prescription can decide whether the entire coverage layer applies at all, and a compounded pathway sits outside that retail stack with its own pricing. Because each component can amplify or cancel another, the only reliable figure is the one you generate for your own plan, indication, and pharmacy on the day you fill. Understanding the interactions, rather than any single component in isolation, is what lets you anticipate the number instead of being surprised by it.

The component that sits above price: your genetics

Every cost component above is external. Your biology is not. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, and MC4R that shape baseline GLP-1, appetite-regulation, and energy-balance biology. It is not a pharmacogenomic test and does not predict response to any specific medication; it is the test-before-you-invest context PlexusDx applies to every protocol conversation. PlexusDx does not sell other GLP-1 category compounds such as retatrutide, which is investigational and not FDA-approved.

Frequently Asked Questions

How much does tirzepatide cost without insurance?

Its list price is roughly $1,059 to $1,069 per month at U.S. list as of April 2026 for Zepbound and Mounjaro. Without insurance and without a savings card, that list price is what cash-pay patients face at most pharmacies. Compounded pathways, savings programs, and discount cards can reduce the total.

Is there a savings card for tirzepatide?

Yes. The manufacturer publishes a savings card for eligible commercially-insured patients that can substantially reduce monthly cost. Independent coupons from GoodRx and SingleCare post discounted prices that vary by pharmacy and change frequently. Government-insurance patients are typically excluded from manufacturer cards, so verify eligibility at fill.

Why is tirzepatide so expensive?

It is a patent-protected branded medication, and the manufacturer sets list price around research-and-development cost recovery, market positioning, and expected payer mix. Prices stayed high partly because demand outpaced manufacturing in 2023 and 2024. Compounded alternatives and savings programs are the primary levers patients use to lower cost.

Are compounded versions cheaper?

Often yes — compounded tirzepatide from licensed 503A pharmacies has historically been priced significantly below list. The trade-offs include regulatory complexity, variation in prescriber oversight, and the FDA's evolving stance on compounding after the 2024 shortage resolution. Talk through those points with a qualified clinician before deciding.

Keep reading across the PlexusDx Education Hub for more evidence-based GLP-1 and metabolic-health explainers.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.